Talking about medical marijuana is inseparable from two important chemical components, THC (tetrahydrocannabinol) and CBD (cannabinol). Both are similar in molecular structure but have completely different pharmacological properties.

THC is the main psychoactive chemical component of cannabis, which can cause excitement and addiction, and is the main cause of cannabis being identified as a drug. In 1964, Israeli scientists first isolated tetrahydrocannabinol from cannabis. In 1988, scientists discovered cannabinoid receptors in the human body, confirming the medical value of THC. Many countries currently recognize the medical value of THC and allow cannabis to be used for medical purposes.

THC molecular structureTHC molecular structure

CBD – No mental activity, no excitement, and addiction, but many medical values ​​similar to THC. In 2017, the World Health Organization stated that cannabinol (CBD) does not adversely affect people’s health. In contrast, cannabidiol can be used in the medical field. In the same year, the World Anti-Doping Agency (WADA) officially removed the Convention on Biological Diversity from the List of Prohibited Substances, which entered into force on January 1, 2018. Currently, European and American CBD products (CBD oil) are very popular in various states and are popular health and nutrition products.

CBD molecular structure

THC molecular structure

Feedback